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Localization of active and inactive kallikrein (kininogenase activity) in
the microdissected rabbit nephron. Active and total (trypsin-activated)
kallikrein were measured in discrete segments of the nephron by their
kininogenase activity. The kinins generated were measured by radio-
immunoassay and the amount of inactive kallikrein was calculated as
the difference between total and active kallikrein. Single nephrons from
collagenase-treated rabbit kidneys (N = 12) were microdissected and
divided into eight segments: (I) glomerulus; (2) proximal convoluted
tubule; (3) cortical thick ascending limb; (4) bright portion of distal
convoluted tubule; (5) granular portion of distal convoluted tubule; (6)
granular portion of cortical collecting tubule; (7) light portion of cortical
collecting tubule; and (8) medullary collecting tubules. After pooled
segments (approximately 50 nephron segments in each assay) were
homogenized and treated with deoxycholic acid, active and total
kallikrein were measured and inactive kallikrein was calculated. Active
and inactive kallikrein were localized in granular portions of the distal
and cortical collecting tubule, which contains more than 85% of the
active and inactive kallikrein found in the total microdissected nephron.
Little or no kallikrein was detected in other segments, including the
bright portion of the distal segment which has the macula densa. The
discrete localization of active and inactive kallikrein suggests a specific
role for renal kallikrein in these nephron segments.
Localisation de Ia kallikréine active et inactive (activité kininogenase)
dans le néphron de lapin microdisséqué. Les kallikréines active et totale
(activëe par Ia trypsine) ont été mesurées dans des segments séparés de
néphron par leur activité kininogénase. Les kinines générées étaient
mesurées par dosages radioimmunologiques, et Ia quantité de kallik-
réine inactive était calculée par difference entre les kallikréines totale et
active. Des nephrons isolés de rein de lapin traités par Ia collagénase (N
= 12) ont été microdisséqués et séparés en huit segments: (1) Ic
glomérule, (2) Ic tube contourné proximal; (3) l'anse ascendante large
corticale; (4) Ia partie brillante du tube contourné distal; (5) Ia partie
granulaire du tube contourné distal; (6) la partie granulaire du tubule
collecteur cortical; (7) Ia partie brillante du tube collecteur cortical; (8)
les tubes collecteurs tubulaires. Aprés que les segments rassemblés
(environ 50 segments nephroniques par dosage) aient Cté homogénéisCs
et traités avec de l'acide désoxycholique des kallikréine actives et
totales ont été mesurées, et La kallikréine inactive calculée. Les
kallikréines actives et inactives ont etc localisées dans les portions
granulaires des tubules distaux et collecteurs corticaux, lesquels con-
tiennent plus de 85% de Ia kallikréine active et inactive trouvés dans
l'ensemble du néphron microdisseque. Ii n'a Cté détecté que peu ou pas
de kallikréine dans les autres segments, notamment Ia partie brillante du
segment distal qui comporte Ia macula densa. La localisation sCparC des
kallikréines active et inactive suggCre un role spCcifique de Ia kalli-
kréine rénale dans ces segments néphroniques.
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Renal kallikrein is an enzyme which releases kinins, potent
vasodilator peptides, from kininogens present in plasma, urine,
and other biological fluids. Kallikrein has been implicated in the
control of renal blood flow and function and may participate in
the pathogenesis of hypertension [1—4]. Furthermore, it has
been reported that urinary kallikrein converts inactive renin to
active renin in vitro [5] and stimulates renin release from
superfused rat renal cortical slices [6]. In the kidney, kallikrein
is found mainly in the cortex, decreasing from the outer to the
inner cortex with very small concentrations in the medulla and
papilla [7, 8]. Using stop-flow techniques, it has been shown
that kallikrein is released into the urine at the site of the distal
nephron 19]. In immunohistochemical studies, Ørstavik et al
[10] localized kallikrein in the distal tubule, while Simson et al
[11] found a broader distribution, including the proximal and
distal tubule and the collecting duct near the tip of the renal
papilla. Tomita, Endow, and Sakai [12] reported esterolytic and
amidolytic activities in the microdissected nephron segments
which were inhibited by aprotinin in the granular portion of the
distal convoluted tubule. However, these studies did not deter-
mine the separate localization of active and inactive kallikrein.
Thus, additional studies on the localization of kallikrein, using a
different methodology, are needed. In this work, we localized
both forms of the enzyme in the microdissected rabbit nephron.
Active and total (trypsin-activated) kallikrein were measured in
discrete segments of the nephron by their kininogenase activity.
The kinins generated were measured by radioimmunoassay
(RIA), and inactive kallikrein was calculated as the difference
between total and active kallikrein. We selected the rabbit
because microdissection of its nephron is easy and because in
the distal tubule, where kallikrein is probably localized, transi-
tions from one segment to another are more abrupt than in other
species [13, 14]. Because the distal nephron consists of heterog-
enous cell types, more precise localization may help us to
clarify kallikrein's physiological role within the kidney.
Methods
We obtained the following materials commercially: medium
199 from GIBCO Labs (Grand Island, New York); hyaluroni-
dase (type I) and soybean trypsin inhibitor (SBTI) from Sigma
Chemical Co. (St. Louis, Missouri); collagenase (142 U/mg)
from Millipore Corp. (Freehold, New Jersey); bovine serum
albumin and deoxycholic acid from Schwarz/Mann (Orange-
burg, New York); trypsin (180 U/mg) from Worthington Bio-
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Fig. 1. Photographic examples of tubular segments microdissected
from collagenase-treated rabbit kidney as described under Methods.
Abbreviations are: Gi, glomerulus; PCT, proximal convoluted tubule;
CAL, cortical thick ascending limb; DCTb, bright portion of distal
convoluted tubule; DCTg, granular portion of distal convoluted tubule;
CCTg, granular portion of cortical collecting tubule; CCT1, light
portion of cortical collecting tubule; MCT, medullary collecting tubule.
chemical Corp. (Freehold, New Jersey); sodium heparin (1000
U/mi) from Elkins-Sinn, Inc. (Cherry Hill, New Jersey); lys-
bradykinin from Bachem (Torrance, California); and, free sodi-
um iodine (Na'251) from New England Nuclear (Boston, Massa-
chusetts) and Amersham Corp. (Arlington Heights, Illinois).
The microdissection medium was medium 199 containing
Earle's salts, L-glutamine, and 25 mi Hepes buffer (final
concentrations: 116.4 mrvi NaCI, 0.8 m MgSO4, 1 mM
NaH2PO4 H20, 26.2 m NaHCO3, 1.8 mM CaC12, 0.006 m Fe
(NO3)3 9H2), 25 m Hepes buffer, pH 7.4). The collagenase
medium composition was identical to the microdissection medi-
um except that it contained phenol (0.2 mM); collagenase
(0.075%); hyaluronidase (0.1%); and bovine serum albumin
(0.1%). The hypo-osmotic solution used for cell membrane
disruption contained 1 mM MgCl2, 0.25 m Na2 ethylenedia-
minetetracetic acid (EDTA) and 1 mtvi Tris-HCI, pH 7.4.
We measured active kallikrein in six rabbits, and both active
and inactive kallikrein were measured in six additional rabbits.
Preparation of single tubule samples. Methods for tissue
preparation and microdissection of tubular segments were
similar to those previously described by Morel, Chabardés, and
Imbert 1151 as modified by Edwards, Jackson, and Dousa 1161.
Briefly, young male New Zealand white rabbits (2.0 to 2.5 kg; N
= 12) maintained on ad libitum food and tap water were
anesthetized with sodium pentobarbital (Nembutal®; 40 mg/kg,
i.v.) and received an intravenous heparin injection of 500 U.
The left kidney was perfused in situ via the left renal artery with
15 ml of cold collagenase medium containing heparin (20 U/mI)
at a flow rate of 1.5 mllmin. The renal vein was then ligated and
additional collagenase solution (approximately 10 ml) was per-
fused until the kidney capsule ruptured. After perfusion, the
kidney was removed quickly and sliced with a razor blade along
the corticomedullary axis. The longitudinal slab was then sliced
into triangular slices which were incubated in aerated (95% 02,
5% C02) collagenase medium at 35°C for 45 to 55 mm. After
incubation, the slices were rinsed thoroughly in microdissection
medium and transferred to petri dishes filled with ice cooled
microdissection medium. Microdissection of the tubules was
performed by hand at 0 to 4°C using thin steel needles under a
stereomicroscope.
Eight segments of the nephron were isolated according to
criteria previously described [15] and analyzed for their kinino-
genase activity (I) glomerulus (G 1); (2) early proximal convolut-
ed tubule (PCT); (3) cortical portion of the thick ascending limb
of the loop of Henle (CAL); (4) bright portion of the distal
convoluted tubule (DCTb); (5) granular portion of the distal
convoluted tubule (DCTg); (6) granular portion of the cortical
collecting tubule (CCTg); (7) light portion of the cortical collect-
ing tubule (CCTI); and (8) medullary collecting tubule (MCT).
Figure 1 shows a photograph of a typical microdissected
nephron. Approximately 50 samples of each nephron segment
were dissected from each kidney, pooled, and then by means of
a narrow polyethylene tubing connected to a micropipette,
transferred in 5 1.d of dissection medium to a plastic cover slip
mounted on a glass slide. The microdissection medium was then
aspirated from the tubular segments and replaced with 5 l of
hypo-osmotic solution. After the samples were frozen rapidly
by placing the glass slide on a block of dry ice, they were stored
at —80°C for approximately 12 hr until assayed for kininogenase
activity. In preliminary studies, we found that storing the
segments at —80°C for 24 hr had no significant effect on
measured kininogenase activity.
Measurement of active kallikrein. Approximately 12 hr after
microdissection 10 xl of cooled hypo-osmotic solution was
added to each frozen sample. The samples were allowed to
thaw at 4°C and were then quickly refrozen by placing the glass
slide on dry ice. Thawing and refreezing were then repeated two
more times. Frozen samples of each nephron segment pool
were then transferred by forceps to micro test tubes to be
incubated in 100 d of 1% deoxycholic acid (pH 8.5) for 30 mm
at 4°C. Since renal kallikrein is membrane bound, its solubiliza-
tion is necessary before it can be measured [81. For the process
of membrane solubilization, we selected deoxycholic acid (1%)
because it is one of the most suitable agents of several we tested
(Triton Xl00, Brij 35, sodium dodecyl sulfate and Melittin;
unpublished results). After membrane solubilization, cellular
structures could no longer be identified.
After the deoxycholic acid mixture had been vortexed for 2 to
3 mm, duplicate aliquots of 5 and 50 .d from each sample were
removed to measure protein and active kallikrein, respectively.
Samples that contained more than 5 jxg protein/assay per tube
were used when we measured only active kallikrein. We
measured kallikrein by its kininogenase activity (kinin-releasing
capability) using a modification of the method of Carretero et al
[17]. To increase the sensitivity of this method, we increased
the incubation time of the renal tissue with the kininogen to 16
hr. To test whether the concentrations of 1—10 phenanthroline
and EDTA used completely inhibited kininase activity, renal
tissue homogenate (5 and 20 sg) without kininogen, and kinino-
gen without tissue were incubated with 50 ng of bradykinin in
the presence of both 3.0 m 1—10 phenanthroline and 30 mM
(final concentrations) EDTA. After 16 hr of incubation, recov-
ery was greater than 99% in both situations.
We also tested for blanks. When incubated without kinino-
gen, the renal tissue did not generate kinins, whereas when
kininogen was incubated without tissue, it generated kinins
(34.5 3.4 pg/mm). For this reason, blanks of kininogen were
run with each incubation. Briefly, to measure active kallikrein,
50 .d of tissue samples treated with the deoxycholic acid were
incubated with 2000 ng (based on kinin release with exhaustive
trypsin treatment) of semipurified dog kininogen as substrate in
the presence of 1—10 phenanthroline (3.0 mM) and EDTA (30
mM) to inhibit kininases, and in the presence of neomycin
(0.1%) and sodium azide (0.1%) as antibacterial and antifungal
agents. The incubation volume was adjusted to 1 ml with 0.1 M
phosphate buffer, pH 8.5. The samples were incubated at 37°C
for 16 hr, and the reaction was stopped by adding 4 ml of 96%
ethanol. After the samples were allowed to stand for 5 mm at
room temperature, they were centrifuged at approximately
x 1300 g for 10 mm at 4°C. The precipitate was washed with I ml
of 80% ethanol and recentrifuged. The combined supernatants
were evaporated under a dry steam of nitrogen to a residual
volume of 0.5 ml. The residue was then brought to the final
volume of 10 ml with 0.1 M Tris-HCI buffer, pH 7.4. Aliquots of
2 to 20 l were tested to determine kinin concentration by RIA.
RIA was performed as previously described [171. The minimum
kinin detectable in the RIA was 2 pg of kallidin per assay tube.
Kininogenase activity of the samples was calculated as the
difference from nonspecific activity (kininogen blank) and was
expressed as picograms of kinins formed per microgram of
tissue protein per minute of incubation.
Measurement of total kallikrein. In a separate series of
experiments, we measured total as well as active kallikrein in
microdissected nephron segments. Inactive kallikrein was cal-
culated as the difference in activity between total kallikrein
(both active and inactive kallikrein) and active kallikrein. Total
kallikrein was obtained by measuring the kininogenase activity
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Fig. 3. Total kallikrein of different nephron segments as a function of
protein content. Each point represents kininogenase activity of approxi-
mately 50 segments after incubation with trypsin from a single experi-
ment (N = 6 experiments). Abbreviations are the same as in Figure 1.
of pooled segments after inactive kallikrein has been activated
with trypsin.
In the preliminary experiments, we determined that the
optimal amount of trypsin to activate inactive renal tissue
kallikrein was 0.1 to 0.5 g/g of tissue. At lower doses, trypsin
activation was not complete and at higher doses some kallikrein
was digested. Maximum activation was obtained in a 15-mm
incubation period. We also determined that doses of soybean
trypsin inhibitor (SBTI) 5 to 50 times higher than that of trypsin
were needed to completely inhibit the kininogenase activity of
trypsin. High concentrations of SBTI were needed because of
the prolonged incubation period used to generate kinins and
because the pH of the incubation mixture (pH 8.5) was not
optimum for the inhibitory effect of SBTI. To measure total
kallikrein, we treated the tissue samples for solubilization of
membrane the day after microdissection and measured their
protein concentrations as described for active kallikrein. To
measure total kallikrein, we incubated duplicate aliquots of 25
lfrom each sample (2.5 to 10 j.g tissue) with 1.25 g of trypsin
in 25 il of 0.1 M phosphate buffer, pH 8.5, for 30 mm in
siliconized glass tubes. The reaction was stopped by adding
62.5 g of SBTI in 50 l of phosphate buffer. The mixture was
incubated for 30 mm at 37°C and for more than 4 hr at room
temperature. At the same time, duplicate aliquots of 25 ILl of
each sample for the measurement of active kallikrein were
incubated similarly, except that trypsin and SBTI were not
added before incubations. Kininogenase activity was then mea-
sured as described above for measurement of active kallikrein.
Determination of protein content in each segment. We mea-
sured protein content in pooled segments of the nephron
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Fig. 2. Active kallikrein of different nephron segments as a function of
protein content. Each point represents kininogenase activity of approxi-
mately 50 segments from a single experiment (N = 12 experiments).
Abbreviations are the same as in Figure 1.
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Fig. 4. The profile of active and inactive kallikrein along the rabbit
nephron. Kininogenase activity was expressed as picograms of kinins
per micrograms of tissue per minute of incubation. Results were given
as means SEM (Active: N = 12; Inactive: N = 6). Diagram below
graph illustrates a schematic rabbit nephron showing subdivisions of
microdissection. The distribution of various cell types in the distal
nephron is depicted by horizontal bars under diagrammatic nephron.
Abbreviations are the same as given in Figure 1.
according to the Lowry method [18], as modified by Edwards,
Jackson, and Dousa [16], for measuring as little as 0.2 g of
protein. Bovine serum albumin was used as a standard. The
final volume of this method was 90 d.
Statistical evaluation of results was performed by Student's
test. A P < 0.05 was considered significant.
Results
Measurement of active kallikrein. The results of 12 experi-
ments to measure active kallikrein are shown in Figure 2. There
was a significant correlation between protein content and
kininogenase activity of the granular portions of the distal
convoluted tubules and the cortical collecting tubule (r = 0.72,
P < 0.05). In the other segments, little or no kininogenase
activity was detected and did not correlate with protein content
of the sample.
Measurement of total kallikrein. The results of six experi-
ments to measure total kallikrein are shown in Figure 3. There
was a significant correlation between protein content and
kininogenase activity of the granular portions of the distal
convoluted and cortical collecting tubule (r = 0.76, P < 0.05).
Little or no kininogenase activity was detected in the other
segments, and no correlation was observed with the protein
content of the sample.
Distribution of active and inactive kallikrein. The profile of
active and inactive kallikrein along the rabbit nephron is shown
in Figure 4. Inactive kallikrein was obtained by the difference
between total and active kallikrein. Most kallikrein was found
to be localized only in the granular portions of the distal
convoluted (DCTg) and the cortical collecting (CCTg) tubule,
which contained more than 85 and 90% of the active and
inactive nephron kininogenase activity, respectively. Inactive
kallikrein accounted for more than two thirds of the total
kininogenase activity in these nephron segments.
Discussion
Recently, microdissected nephron segments have been used
to determine precise localization of different enzymes along the
nephron [14, 151 in an attempt to understand the physiological
role of these enzymes in the nephron. In this study, we used this
technique to determine the localization of active and inactive
kallikrein in discrete segments of the rabbit nephron. Our
results indicate that both active and inactive kallikrein are
localized in the granular portions of the distal convoluted and
the cortical collecting tubule. We did not find active or inactive
kallikrein in any other nephron segments, and when a small
amount of activity was found it did not correlate with the
protein concentration of the sample. Thus, the data indicate
that active and inactive kallikrein are distributed discretely in
the rabbit nephron. These results agree with those of Tomita,
Endow, and Sakai [121, who studied esterolytic activity and
amidolytic activity along the microdissected rabbit nephron and
found the activities in the proximal tubule and the granular
portion of the distal tubule. However, since they found that
aprotinin inhibited activity only in the granular portions of the
distal tubule, they suggested that renal kallikrein was localized
only in the granular portions of the distal tubule. However,
esterolytic and amidolytic methods are not specific enough to
determine kallikrein in tissue [19]. Furthermore, aprotinin is a
polyvalent inhibitor and may inhibit renal serine proteases other
than kallikrein [201.
In our study, we measured kininogenase activity, although
kallikrein may not account for all kinin-generating enzymes in
the kidney. Recently, it has been reported that urinary esterase
A2 has some kininogenase activity [211. However, when we
incubated the rat urinary esterase A2 with our dog kininogen
preparation, we found very little kininogenase activity per unit
of esterase as compared to kallikrein (less than 5%) (unpub-
lished results). Thus, in all probability, most kininogenase
activity in the isolated nephron segment is kallikrein.
Inactive kallikrein has been found in the basolateral mem-
brane of rat kidney [22] as well as human urine [23]. Our study,
to our knowledge, is the first attempt to localize inactive
kallikrein in the nephron. We also found significant amounts of
inactive kallikrein is distributed in the same segments of the
nephron (granular portion of the distal and cortical collecting
tubule) as active kallikrein. The concentration of inactive
kallikrein was two or more times higher than the active form.
The identical localization of the inactive and active forms
suggests that the inactive form is prekallikrein. However, we
could not determine conclusively from this study whether
inactive kallikrein is the zymogen form of the enzyme (prekal-
likrein) or an enzyme-inhibitor complex.
Kallikrein activity in renal homogenates is generally mea-
sured with samples that contain more than milligram quantities
of protein [7, 24]. However, we modified assay conditions to
detect kininogenase activity with samples that contain micro-
gram quantities of protein per assay tube by extending the
incubation period to 16 hr. Since kinin generation increased
with incubation time, we measured femtomole quantities of
kallikrein. Nevertheless, this prolonged incubation can create
new problems, and caution should be taken to show that
kininases are inhibited completely. We inhibited kininases
because our method recovered greater than 99% of exogenously
added bradykinin after 16 hr of incubation with either tissue
•Active kallikrein
Inactive kallikrein
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homogenate or substrate. Our kininogen, when incubated with-
out tissue, generates a small amount of kinin, and although we
attempted to inhibit this kininogenase activity by adding differ-
ent inhibitors (SBTI and phenylmethylsulfonylfluoride), we
were not successful (unpublished results). For this reason we
included kininogen blanks with each assay and subtracted the
kinins generated from each sample value. To determine inactive
kallikrein by activation with trypsin, we took special precau-
tions to titrate the amount of trypsin to be used. With too little
trypsin, we found that the activation was incomplete. Also,
when we used too much trypsin, the kininogenase activity
decreased, suggesting that an excess of trypsin was digesting
the kallikrein. At the end of the activation, we took special
precautions to completely inhibit the trypsin with SBTI, since
trypsin also has kininogenase activity.
Recent studies showed that the granular portions of the distal
convoluted and cortical collecting tubules have similar morpho-
logical [25] and functional [261 characteristics. They form a
single nephron segment called the connecting tubule, which
consists of the connecting tubule and the intercalated cells.
Since the connecting tubule cells localize only in the granular
distal and collecting segment, and the intercalated cells are
distributed thoroughly from the granular distal tubule to the
medullary collecting tubule, it is reasonable to assume that
kallikrein is synthesized in the connecting tubule cell.
Using immunohistochemical techniques, Ørstavik and ma-
gami [27] recently reported that kallikrein was detected in the
convoluted distal tubule of the rat kidney beginning at a point
distal to the juxtaglomerular apparatus and extending along the
distal tubule to a point ending in a collecting duct. However,
there is presently no convincing way to differentiate between
the bright and granular portions of the distal convoluted tubule
or granular and light portions of the cortical collecting tubule in
immunohistochemical studies. Moreover, the discrepancy be-
tween our results and those of Ørstavik and Inagami [271 might
be explained by species differences. The well-delineated seg-
mentation of the distal tubule into successive portions observed
in the rabbit is not present in the rat, rather, the four different
cell types present are discretely in the four segments of the
rabbit distal tubule and are distributed in variable portions along
the full length of the rat distal tubule [13, 141. Nevertheless, our
studies in conjunction with Ørstavik and Inagami [27] indicate
that no kallikrein is found in the area of the macula densa. In the
microdissected nephron, the macula densa was included in the
bright portion of the distal convoluted tubule, and in this
segment we found very little or no active and inactive kallikrein
(Fig. 4). Thus, the anatomical distribution of kallikrein in the
nephron does not support the hypothesis that renal kallikrein
activates inactive renin.
Simson et al [11] reported a broad distribution of kallikrein in
the rat nephron including the proximal and distal tubules and
the collecting duct near the tip of the papilla. In the proximal
tubule, kallikrein was observed as reabsorption droplets. Since
the kidney removes immunoreactive kallikrein from plasma
[28], these reabsorption droplets may be immunoreactive frag-
ments of filtered glandular kallikrein incorporated in this seg-
ment of the nephron by endocytosis. Because these fragments
will probably not have kininogenase activity, they would not be
detected by our method. The presence of kallikrein in the
collecting duct near the papilla is more difficult to explain. In
our work, we studied only the rabbit medullary collecting
tubules in the outer medulla; we found no kallikrein. In previ-
ous work, we determined kallikrein in the dog renal medulla and
papilla and found very small concentrations in this area of the
kidney [7]. In immunohistochemical studies, Ørstavik et al [10]
and Ørstavik and Inagami [27] found kallikrein only in the rat
distal tubule. The reason for the discrepancy between these
findings is not clear, although it may involve the specificity of
the antibodies and the different techniques and species used.
In conclusion, more than 85 and 90% of the active and
inactive kallikrein, respectively, was found in the granular
portions of the distal and cortical collecting tubules. Very little
or no kallikrein was found in the segment with the macula densa
(bright portion of the distal convoluted tubule) or in any other
part of the nephron. Furthermore, since the only unique cells of
the connecting tubule segment of the rabbit nephron are the
connecting tubule cells, kallikrein may be used as a marker of
these cells. The discrete localization of active and inactive
kallikrein suggests a specific role for renal kallikrein in these
nephron segments.
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